“The RNA team is great. Sam and Kayvon have done an exceptional job working with my companies for over a decade. They deliver on time and I don’t have to spend time getting them up to speed because they already know healthcare and medtech.”
“I’ve worked with the RNA team on a number of valuation matters, large and small. These guys know their stuff. Whether using them to assist with large licensing transaction negotiations to simple tax and financial reporting work, they understand and they deliver.”
“I love the RNA team. They get healthcare and we’ve worked with the team both in valuation advisory capacities as well as on strategic projects for us as we take SmithRx to the next level. These guys get it!”
“I’ve worked with the RNA team for over a decade across my current and previous companies. They are our go to valuation firm for valuation because they know the industry, are responsive and understand the nuances that drive transactions just as much as accounting.”
A companion to our peer-reviewed paper in JPMSA... [read more]
[Extended JPMSA article summary] The financial tools most... [read more]
Most founders and CEOs understand bad clients. A... [read more]
It’s Not Always Positive Ask a biotech CEO... [read more]
Unfortunately, this actually happened. I. The Worldview Before... [read more]
Why Biotech Executives and Investors Should Understand the... [read more]
Data-Driven Narrative for Capital Formation in Life Sciences... [read more]
Since 2015, RNA Advisors has provided valuation, transactional... [read more]
RNA Advisors, LLC, a leading valuation and strategic... [read more]
Enter your email address below to receive updates from RNA Advisors.
